NEOCRYSTEPIN 25mg / 0.5mg / 0.1mg dragees medication leaflet

C02LA51 chlorthalidone + dihydroergocrystine + reserpine • Cardiovascular system | Antihypertensives and diuretics in combination | Rauwolfia alkaloids and diuretics in combination

This combination of chlorthalidone, dihydroergocristine, and reserpine is used for the treatment of hypertension. Chlorthalidone is a thiazide diuretic that reduces blood volume, dihydroergocristine is an ergot derivative that improves circulation, and reserpine works by reducing sympathetic nervous system activity.

The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and undergo regular check-ups to monitor blood pressure.

Patients should be aware of potential side effects, such as dizziness, fatigue, or dry mouth. It is important to inform the doctor of any unusual symptoms.

Common side effects include dizziness, fatigue, dry mouth, and nausea. In rare cases, severe reactions such as depression or electrolyte imbalances may occur. Patients should be informed of these risks before starting treatment.

General data about NEOCRYSTEPIN 25mg / 0.5mg / 0.1mg

Substance: chlorthalidone + dihydroergocrystine + reserpine

Date of last drug list: 01-07-2013

Commercial code: W01805001

Concentration: 25mg / 0.5mg / 0.1mg

Pharmaceutical form: dragees

Quantity: 30

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.